Clinical trial
Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With…
NCT00003309 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003309 |
|---|---|
| Title | Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer |
| Official title | A Phase II Trial of Preradiation Multiagent Chemotherapy for Adults With "Poor Risk" Medulloblastoma, PNET, and Disseminated Ependymoma |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH SWOG Cancer Research Network |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, cisplatin, cyclophosphamide, etoposide, vincristine sulfate, adjuvant therapy, radiation therapy |
| Enrollment | 33 |
| Start date | May 4, 1999 |
| Primary completion | Mar 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 22, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: